Loomis, Sayles & Company’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-442,324
Closed -$5.29M 958
2018
Q2
$5.29M Sell
442,324
-161,571
-27% -$2.16M 0.01% 520
2018
Q1
$9.3M Sell
603,895
-98,992
-14% -$1.65M 0.02% 442
2017
Q4
$11.5M Sell
702,887
-320,064
-31% -$6.19M 0.02% 402
2017
Q3
$23.4M Buy
1,022,951
+166,920
+19% +$3.56M 0.05% 238
2017
Q2
$24M Buy
856,031
+231,964
+37% +$6.42M 0.06% 213
2017
Q1
$19.2M Buy
+624,067
New +$17.6M 0.05% 258

Other funds holding DBD

Loomis, Sayles & Company's DBD Position: Q3 2018 in Review

Loomis, Sayles & Company sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2018, closing a stake of 442,324 shares — an estimated $5.29M sold.

Loomis, Sayles & Company first reported a position in DBD in Q1 2017 and held it in 6 quarters. The position peaked at $24M in Q2 2017. 201 funds tracked by Wall St. Rank hold DBD as of Q3 2018.

  • Loomis, Sayles & Company reported no remaining Diebold Nixdorf Incorporated position as of Q3 2018 after selling out during the quarter.
  • Loomis, Sayles & Company sold 442,324 Diebold Nixdorf Incorporated shares in Q3 2018, an estimated $5.29M.
  • Loomis, Sayles & Company first reported a position in Diebold Nixdorf Incorporated in Q1 2017 and held it in 6 quarters.
  • Loomis, Sayles & Company's Diebold Nixdorf Incorporated position peaked at $24M in Q2 2017.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2018.

Based on Loomis, Sayles & Company's 13F filing for Q3 2018, filed 13 Nov 2018.